Recurrent malignant gliomas and 5-ALA fluorescence guidance: a multicentre phase II study

A. Nabavi, H. Thurm, B. Zountsas, T. Pietsch, H. Lanfermann, U. Pichlmeier & H.M. Mehdorn
Objective: To assess the feasibility of 5-Aminolevulinic acid (5ALA) fluorescence-guided resection for recurrent malignant brain tumours. Methods: We conducted a multicentre prospective, single-arm, uncontrolled phase II study. 36 patients with recurrent glioma (WHO grade III/IV) received 5-ALA[for full text, please go to the a.m. URL]